A carregar...
Dulaglutide and Insulin: How Can the AWARD Studies Help Guide Clinical Practice?
The glucagon-like peptide 1 receptor agonist (GLP-1RA) dulaglutide has many characteristics to recommend it both as a second-line agent and as an alternative to or in combination with insulin. This commentary summarises recent updates to diabetes management guidelines regarding the use of GLP-1RAs s...
Na minha lista:
| Publicado no: | Diabetes Ther |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Healthcare
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7376989/ https://ncbi.nlm.nih.gov/pubmed/32564337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00863-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|